Sebastián Díaz-Pérez

ORCID: 0000-0002-3048-9906
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Animal testing and alternatives
  • Respiratory viral infections research
  • Cell Image Analysis Techniques
  • Animal Disease Management and Epidemiology
  • Dementia and Cognitive Impairment Research
  • Influenza Virus Research Studies
  • Acute Ischemic Stroke Management
  • Meta-analysis and systematic reviews
  • Computational Drug Discovery Methods
  • Neurological Disease Mechanisms and Treatments

Yale University
2022-2024

University of Pennsylvania
2017

Significance The majority of influenza vaccine antigens are prepared in chicken eggs. Human strains grown eggs often possess adaptive mutations that increase viral attachment to cells. Most these the hemagglutinin protein, which functions as a factor. Here, we identify mutation current egg-adapted H3N2 strain alters antigenicity. We show ferrets and humans exposed produce antibodies poorly neutralize viruses circulated during 2016–2017 season. These studies highlight challenges associated...

10.1073/pnas.1712377114 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2017-11-06

Human diseases may be modeled in animals to allow preclinical assessment of putative new clinical interventions. Recent, highly publicized failures large trials called into question the rigor, design, and value assessment. We established Stroke Preclinical Assessment Network (SPAN) design implement a randomized, controlled, blinded, multi-laboratory trial for rigorous candidate stroke treatments combined with intravascular thrombectomy. Efficacy futility boundaries multi-arm multi-stage...

10.1126/scitranslmed.adg8656 article EN Science Translational Medicine 2023-09-20

Cerebral ischemia and reperfusion initiate cellular events in brain that lead to neurological disability. Investigating these provides ample targets for developing new treatments. Despite considerable work, no such therapy has translated into successful stroke treatment. Among other issues—such as incomplete mechanistic knowledge faulty clinical trial design—a key contributor prior translational failures may be insufficient scientific rigor during preclinical assessment: nonblinded outcome...

10.1161/strokeaha.121.038047 article EN Stroke 2022-03-31

Abstract Vascular dementia (VaD) refers to a variety of dementias driven by cerebrovascular disease and is the second leading cause globally. VaD may be caused ischemic strokes, intracerebral hemorrhage, and/or cerebral small vessel disease, commonly identified as white matter hyperintensities on MRI. The mechanisms underlying these lesions in periventricular brain are poorly understood. In this study we perform an extensive transcriptomic analysis human postmortem patients with goal...

10.1101/2024.12.06.627202 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-12-11
Coming Soon ...